0001209191-19-031833.txt : 20190521 0001209191-19-031833.hdr.sgml : 20190521 20190521182722 ACCESSION NUMBER: 0001209191-19-031833 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190517 FILED AS OF DATE: 20190521 DATE AS OF CHANGE: 20190521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mow Jonathan P CENTRAL INDEX KEY: 0001313942 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38697 FILM NUMBER: 19843600 MAIL ADDRESS: STREET 1: 2025 1ST AVENUE STREET 2: SUITE 800 CITY: SEATTLE STATE: WA ZIP: 98121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (610) 981-6500 MAIL ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-17 0 0001169245 PhaseBio Pharmaceuticals Inc PHAS 0001313942 Mow Jonathan P C/O PHASEBIO PHARMACEUTICALS, INC. 1 GREAT VALLEY PARKWAY, SUITE 30 MALVERN PA 19355 1 1 0 0 Chief Executive Officer Common Stock 2019-05-17 4 M 0 19913 2.27 A 71112 D Common Stock 2019-05-20 4 M 0 19131 1.24 A 90243 D Employee stock option (right to buy) 2.27 2019-05-17 4 M 0 19913 0.00 D 2016-12-03 2022-12-21 Common Stock 19913 0 D Employee stock option (right to buy) 1.24 2019-05-20 4 M 0 19131 0.00 D 2018-03-14 2024-03-31 Common Stock 19131 0 D /s/ John Sharp, Attorney-in-fact 2019-05-21